Hillhurst Biopharmaceuticals
Hillhurst, a US-based company, innovates therapeutic low-dose carbon monoxide technology to combat inflammatory diseases and sickle cell disease.
Founded
2012Hillhurst, a US-based company, innovates therapeutic low-dose carbon monoxide technology to combat inflammatory diseases and sickle cell disease.
Official pages and third-party coverage in one index.
hillhurstbio.com7 items across 6 mapped pages · Crawled Sep 25, 2026
Official pages and third-party coverage in one index
WHO WE ARE “We founded Hillhurst to liberate Sickle Cell Disease patients from the horrendous, recurrent, lifelong severe painful episodes and accompanying organ injury of this life limiting disease.” Management Team and Key Advisors Andrew Gomperts President and Chief Executive Officer Before
CONTACT US Hillhurst Biopharmaceuticals, Inc. 3030 Bunker Hill St., Suite 117C OSan Diego, CA 92109 Contact Form
Medical Gas in Liquid Advanced Stability System Up until now, many therapeutic agents could only be delivered using inhaled methods, limiting their dosing accuracy, efficacy and safety. Hillhurst’s proprietary GLASS platform enables the novel oral delivery of these agents, making them more safe, convenient, accurate, and suitable for at-home administration. We’ve developed a unique
Legal Information and Privacy and FCOI Policy Legal Information Terms of UseThank you for visiting the Hillhurst Biopharmaceuticals, Inc. (“Hillhurst”) website. The materials on this Web site are provided as a service to our investors, to the media, and to research and medical professionals seeking general information about our technology and
Medical Gas in Liquid Advanced Stability System Up until now, many therapeutic agents could only be delivered using inhaled methods, limiting their dosing accuracy, efficacy and safety. Hillhurst’s proprietary GLASS platform enables the novel oral delivery of these agents, making them more safe, convenient, accurate, and suitable for at-home administration. We’ve developed a unique